Lumexa Imaging Company Profile

Background

Overview

Lumexa Imaging Holdings, Inc., formerly known as US Radiology Specialists, is a leading provider of outpatient diagnostic imaging services in the United States. Established in 2018 and headquartered in Raleigh, North Carolina, the company operates over 180 imaging centers across 13 states, offering a comprehensive range of services including MRI, CT, PET, X-ray, ultrasound, and mammography.

Mission and Vision

Lumexa Imaging is committed to expanding access to high-quality imaging through compassionate care, aiming to improve lives and advance healthcare nationwide. The company envisions becoming the partner of choice for leading health systems and radiologists by delivering clinically excellent, cost-effective care rooted in deep community connections.

Industry Significance

As one of the nation's largest outpatient imaging providers, Lumexa Imaging plays a pivotal role in enhancing diagnostic capabilities and patient care. Its extensive network and innovative services contribute significantly to the healthcare sector's efficiency and accessibility.

Key Strategic Focus

Core Objectives

• Expansion of Imaging Centers: Lumexa Imaging focuses on increasing its footprint by opening new centers and forming joint ventures with health systems.

• Technological Integration: The company emphasizes the adoption of advanced technologies, including AI, to improve imaging quality and operational efficiency.

• Patient-Centric Services: Enhancing patient experience through innovative solutions like Scanslated® reports, which improve comprehension and engagement.

Areas of Specialization

• Outpatient Imaging Services: Providing a full spectrum of diagnostic imaging services in outpatient settings.

• Joint Ventures: Collaborating with leading health systems to expand service offerings and reach.

Key Technologies Utilized

• Artificial Intelligence (AI): Implementing AI to accelerate scan times and streamline patient scheduling.

• Advanced Imaging Equipment: Utilizing state-of-the-art MRI, CT, PET, and mammography technologies.

Primary Markets Targeted

• Outpatient Diagnostic Imaging: Serving patients seeking non-hospital-based imaging services.

• Healthcare Systems: Partnering with hospitals and clinics to provide comprehensive imaging solutions.

Financials and Funding

Funding History

• Initial Public Offering (IPO): In December 2025, Lumexa Imaging raised $462.5 million through its IPO, significantly surpassing the initial target of $200 million.

Recent Funding Rounds

• IPO Details: The IPO involved the issuance of 25 million shares at $18.50 per share, with shares closing at $18.53 on the first day of trading.

Notable Investors

• Welsh, Carson, Anderson & Stowe: A private equity firm specializing in healthcare and technology sectors, which has been a significant investor in Lumexa Imaging.

Utilization of Capital

• Expansion Initiatives: The funds are allocated towards opening new imaging centers and forming joint ventures.

• Technological Advancements: Investing in AI and state-of-the-art imaging equipment to enhance service quality.

Pipeline Development

Key Pipeline Candidates

• AI-Powered Breast Arterial Calcification Assessment: A pilot program launched in New Jersey, with plans for expansion to other regions in 2026.

Stages of Development

• Implementation: The AI assessment is currently in the pilot phase, with positive patient adoption rates.

Target Conditions

• Breast Arterial Calcification: A condition detectable through mammography, with the AI tool aiming to improve detection and patient outcomes.

Anticipated Milestones

• Expansion: Wider deployment of the AI assessment across Lumexa Imaging centers in 2026.

Technological Platform and Innovation

Proprietary Technologies

• Scanslated® Reports: Innovative, patient-friendly reports designed to enhance comprehension and engagement.

Significant Scientific Methods

• AI Integration: Utilizing artificial intelligence to improve imaging processes and patient scheduling.

Leadership Team

Executive Profiles

• Caitlin Zulla: Chief Executive Officer and Director. Under her leadership, Lumexa Imaging has expanded its network and integrated advanced technologies.

• J. Anthony Martin: Chief Financial Officer. He oversees financial strategies and operations, contributing to the company's growth and stability.

• James Walker: Chief Accounting Officer. Responsible for financial reporting and compliance, ensuring transparency and accuracy in financial matters.

Competitor Profile

Market Insights and Dynamics

• Market Size: The U.S. diagnostic imaging services market is approximately $140 billion, encompassing inpatient, outpatient, and freestanding centers.

• Growth Potential: Increasing demand for outpatient imaging services presents significant growth opportunities.

Competitor Analysis

• Option Care Health (OPCH): Focuses on home and alternate site infusion services.

• RadNet (RDNT): Operates outpatient imaging centers, offering services similar to Lumexa Imaging.

• Sotera Health (SHC): Provides sterilization and lab services, with some overlap in healthcare services.

• Celcuity (CELC): Specializes in cellular analysis for cancer diagnostics.

• BillionToOne (BLLN): Focuses on molecular diagnostics, with limited overlap in imaging services.

Strategic Collaborations and Partnerships

• Joint Ventures: Lumexa Imaging has established over 85 joint ventures with leading health systems, expanding its reach and service offerings.

Operational Insights

• Competitive Advantages: Lumexa Imaging's extensive network, technological integration, and patient-centric services position it favorably in the outpatient imaging market.

Strategic Opportunities and Future Directions

Strategic Roadmap

• Expansion: Continue opening new imaging centers and forming joint ventures to increase market presence.

• Technological Leadership: Advance AI integration and develop innovative patient engagement tools.

Future Business Directions

• Service Diversification: Explore additional diagnostic services to offer comprehensive care solutions.

• Geographic Expansion: Enter new markets to broaden the patient base and service availability.

Opportunities for Expansion

• Emerging Markets: Target underserved regions with high demand for outpatient imaging services.

• Technological Innovations: Leverage AI and other technologies to enhance service delivery and patient outcomes.

Contact Information

• Official Website: www.lumexaimaging.com

• Social Media: LinkedIn: Lumexa Imaging

• Headquarters: Raleigh, North Carolina